Registry for women with vasculitis during pregnancy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather information about the experiences of women with various types of vasculitis who are pregnant. Participants will complete online surveys assessing their vasculitis severity, pregnancy-related experiences, and outcomes at multiple points during their pregnancy and postpartum. The surveys are designed to be accessible in several languages, including Spanish, Portuguese, Italian, and Turkish. Data collected will be managed by the University of South Florida's Data Management and Coordinating Center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Women 18 years of age or older with one of the following diseases may take part in the study:

   * Behçet's disease;
   * Central nervous system (CNS) vasculitis;
   * Cryoglobulinemic vasculitis (Cryoglobulinemia);
   * Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
   * Giant Cell (Temporal) Arteritis (GCA);
   * Granulomatosis with polyangiitis (also called Wegener's);
   * IgA vasculitis (Henoch-Schoenlein purpura);
   * Microscopic polyangiitis (MPA);
   * Polyarteritis nodosa (PAN);
   * Takayasu's arteritis (TAK);
   * Urticarial vasculitis;
   * Other/Suspected Diagnosis.
2. Women must be pregnant (self-report) at the time of enrollment into the registry.

Exclusion Criteria:

1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
2. Unable to provide consent.

Where it's running

• University of South Florida Data Management and Coordinating Center
  Tampa, Florida, United States Recruiting

Study contacts

• Study coordinator: Christine Yeung
• Email: christine.yeung@pennmedicine.upenn.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating skin lesions in patients with various types of vasculitis

  This study is testing how skin lesions from different types of vasculitis look under a microscope to help doctors better understand and treat these conditions.

  Recruiting at 4 sites University of Pennsylvania · Los Angeles, California and 9 other locations · NCT03004326

• Ocular Symptoms in ANCA-Associated Vasculitis

  This study tests ocular changes in adults with GPA, MPA, or related vasculitis to see how the eyes are involved.

  Recruiting Military Institute od Medicine National Research Institute · Warsaw · NCT07664709

• Survey on long-term use of avacopan for certain autoimmune diseases

  This study looks at how well and safely avacopan works for Japanese patients with certain autoimmune diseases over a long time.

  Recruiting Kissei Pharmaceutical Co., Ltd. · Multiple Locations · NCT06758271

• Longitudinal investigation of central nervous system vasculitis

  This study is trying to learn more about primary central nervous system vasculitis by following patients over three years to see how the disease affects them and to find better ways to measure its activity and outlook.

  Recruiting at 6 sites University of Pennsylvania · Rochester, Minnesota and 5 other locations · NCT05734404

• Benralizumab in EGPA: real-world effectiveness and safety

  This is a real-world study checking how well and safely benralizumab works for adults with eosinophilic granulomatosis with polyangiitis (EGPA).

  Recruiting European EGPA Study Group · Florence, Italy · NCT07815886

• I-FABP as a Predictor of Gut Involvement in Pediatric IgA Vasculitis

  This study checks if a blood marker called I-FABP can flag gut involvement in kids with IgA vasculitis by testing blood at diagnosis and again in 2–4 weeks.

  Recruiting Bursa City Hospital · Bursa, Bursa · NCT07664228

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.